Literature DB >> 9352951

Pathology of diffuse malignant pleural mesothelioma.

J M Corson1.   

Abstract

An accurate diagnosis is essential to a rational approach to the treatment of diffuse malignant pleural mesothelioma and generally requires pathological examination with the application of special techniques. In recent years, immunohistochemistry has greatly abetted the distinction of mesothelioma from its many morphological mimics, yet diagnostic difficulties still remain because reactive hyperplasias and diverse tumors closely mimic mesothelioma. Mesotheliomas are classified into epithelial, mixed, sarcomatoid and undifferentiated types, based on conventional histological examination. The classification provides important prognostic information. Furthermore, differential diagnosis is directly related to histological type. Although such special techniques as histochemistry and electron microscopy continue to play an important role in some cases, immunohistochemistry often has replaced these in distinguishing epithelial-type mesothelioma from metastatic adenocarcinoma. It is also helpful in distinguishing sarcomatoid mesothelioma from it numerous morphological mimics. The distinction of mesothelioma from reactive mesothelial proliferations is still based on morphological examination and may be quite problematic. Recent cytogenetic studies, which have identified characteristic clonal deletions in mesotheliomas, give promise of providing valuable assistance in this distinction in the future.

Entities:  

Mesh:

Year:  1997        PMID: 9352951

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  7 in total

1.  Current surgical management of malignant pleural mesothelioma.

Authors:  Lambros Zellos; David J Sugarbaker
Journal:  Curr Oncol Rep       Date:  2002-07       Impact factor: 5.075

2.  25-year old male with pleural thickening.

Authors:  Abhilasha Ahuja; D Gothi; G Amonkar; J M Joshi
Journal:  Lung India       Date:  2008-04

Review 3.  Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors.

Authors:  Shoshana J Weiner; Siyamek Neragi-Miandoab
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-12       Impact factor: 4.553

4.  Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma.

Authors:  V H Gerbaudo; S Britz-Cunningham; D J Sugarbaker; S T Treves
Journal:  Thorax       Date:  2003-12       Impact factor: 9.139

5.  FDG PET/CT Response Evaluation in Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and Chemotherapy.

Authors:  Giovenzio Genestreti; Andrea Moretti; Sara Piciucchi; Noemi Giovannini; Riccardo Galassi; Emanuela Scarpi; Marco Angelo Burgio; Dino Amadori; Stefano Sanna; Venerino Poletti; Federica Matteucci; Giampaolo Gavelli
Journal:  J Cancer       Date:  2012-06-01       Impact factor: 4.207

6.  Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors.

Authors:  Shoshana J Weiner; Siyamek Neragi-Miandoab
Journal:  J Carcinog       Date:  2008-07-28

7.  Four immunohistochemical assays to measure the PD-L1 expression in malignant pleural mesothelioma.

Authors:  Takuya Watanabe; Katsuhiro Okuda; Takayuki Murase; Satoru Moriyama; Hiroshi Haneda; Osamu Kawano; Keisuke Yokota; Tadashi Sakane; Risa Oda; Hiroshi Inagaki; Ryoichi Nakanishi
Journal:  Oncotarget       Date:  2018-04-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.